PCI-24781(Abexinostat),广谱组蛋白去酰基化酶(HDAC)抑制剂

PCI-24781 (Abexinostat) (订货以英文为准)

编号:P126975
CAS号:783355-60-2
分子式:C21H23N3O5
分子量:397.42
货号 品牌 包装 目录价 您的价格 库存 数量 购买
P126975-5mg 阿拉丁 5mg ¥720.90
P126975-50mg 阿拉丁 50mg ¥3604.90
P126975-10mg 阿拉丁 10mg ¥1029.90
P126975-1mg 阿拉丁 1mg ¥332.90
产品名称 PCI-24781 (Abexinostat)
中文名称 PCI-24781(Abexinostat),广谱组蛋白去酰基化酶(HDAC)抑制剂
CAS号 783355-60-2
分子式(M.F.) C21H23N3O5
分子量(M.W.) 397.42
储存条件 -20°C储存
溶解性DMSO ≥78mg/mL Water <1.2mg/mL Ethanol <1.2mg/mL
存贮条件储存温度-20°C
应用An HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, and HDAC10 inhibitor.
产品介绍PCI-24781 (Abexinostat)是一种新型的pan-HDAC抑制剂,靶向作用于HDAC1,Ki为7 nM,对HDACs 2, 3, 6,和10有适中的抑制性,但比作用于HDAC8选择性强40倍。
备注PCI-24781 is a novel pan-HDAC inhibitor mostly targeting HDAC1 with Ki of 7 nM, modest potent to HDACs 2, 3, 6, and 10 and greater than 40-fold selectivity against HDAC8. Phase 1/2.
生化机理PCI-24781 is a broad spectrum hydroxamic acid-based inhibitor of HDAC that shows antitumor activity in vitro. PCI-24781 inhibited pure recombinant HDAC1 with a Ki of 0.007 Mmol/L, as well as HDAC2, HDAC3/SMRT, HDAC6, HDAC8, and HDAC10 in the nanomolar range. Antitumor activity of PCI-24781 was observed in all 10 tumor cell lines tested, with GI50% values ranging from 0.15 to 3.09 μmol/L.
别名PCI 24781; 3-[(二甲基氨基)甲基]-N-[2-[4-[(羟基氨基)羰基]苯氧基]乙基]-2-苯并呋喃甲酰胺;CRA 024781; CRA 24781; PCI 24781; Abexinostat;3-[(Dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)carbonyl]phenoxy]ethyl]-2-benzofurancarboxamide
搜索质检报告(COA)
搜索MSDS
相关产品
¥ 400.00 SBJ-RBC-S004-100ml
¥ 1150.00 A0357-50μl
¥ 1150.00 A5431-50μl
¥ 825.00 SF-150-1箱
CAS号:27519-02-4
¥ 268.00 T-63624+1ml
CAS号:13389-42-9
¥ 232.00 M68521-1ML
CAS号:14919-01-8
¥ 251.00 M68518-1ML
CAS号:130-22-3
¥ 98.00 A835626-100ml